This bill prohibits the Secretary of Health and Human Services from declaring or using a public health emergency with respect to abortion under the Public Health Service Act. Any such declaration already in effect on the date of the bill's enactment would be immediately terminated. The legislation also imposes significant limitations on abortion drugs, specifically prohibiting the exercise of enforcement discretion regarding their risk evaluation and mitigation strategies (REMS). It mandates the reinstatement of the in-person dispensing requirement for abortion drugs, ensuring they are dispensed only in clinics, medical offices, and hospitals by or under the supervision of a certified health care provider. Furthermore, the bill prevents any reduction in protections under the REMS for abortion drugs until every state submits comprehensive abortion data to the Centers for Disease Control and Prevention's surveillance system. This mandatory data includes variables such as maternal age, gestational age, abortion method, and whether the child survived the abortion, and the in-person dispensing requirement cannot be waived.
Referred to the House Committee on Energy and Commerce.
Health
AbortionDrug safety, medical device, and laboratory regulationDrug therapyGovernment information and archivesHealth information and medical recordsPrescription drugs
Protecting Life from Chemical Abortions Act
USA119th CongressHR-1525| House
| Updated: 2/24/2025
This bill prohibits the Secretary of Health and Human Services from declaring or using a public health emergency with respect to abortion under the Public Health Service Act. Any such declaration already in effect on the date of the bill's enactment would be immediately terminated. The legislation also imposes significant limitations on abortion drugs, specifically prohibiting the exercise of enforcement discretion regarding their risk evaluation and mitigation strategies (REMS). It mandates the reinstatement of the in-person dispensing requirement for abortion drugs, ensuring they are dispensed only in clinics, medical offices, and hospitals by or under the supervision of a certified health care provider. Furthermore, the bill prevents any reduction in protections under the REMS for abortion drugs until every state submits comprehensive abortion data to the Centers for Disease Control and Prevention's surveillance system. This mandatory data includes variables such as maternal age, gestational age, abortion method, and whether the child survived the abortion, and the in-person dispensing requirement cannot be waived.
AbortionDrug safety, medical device, and laboratory regulationDrug therapyGovernment information and archivesHealth information and medical recordsPrescription drugs